Traws Pharma, Inc. — Director's Dealing 2019

Jul 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2019-07-26

Reporting Person: Reddy E Premkumar (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-26	Stock Option (right to purchase)	$3.39	A	5833	Acquired	2029-07-26	Common Stock (5833)	Direct

Footnotes

F1: These options vest 100% on the first anniversary of the grant date.